
FDA panel is split on updates to COVID shots as questions loom for fall vaccinations
Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this fall and winter.
Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this fall and winter.
Top officials for the Food and Drug Administration have laid out new requirements for yearly updates to COVID shots.
An overhaul of the system for approval and use of vaccines is, among other things, creating uncertainty around next fall's COVID-19 vaccinations.
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from Novavax.
Before this transplant, only four other Americans had received experimental xenotransplants of gene-edited pig organs.